Fundz

Neurolief raises $6M in funding from BrainsWay Ltd to expand operations and R&D efforts after FDA approval of Proliv™Rx.

PRIVATEMar 30, 2026

Amount Raised

$6 Million

Round Type

Funding Round

TampaBiotechnologyHealth CareMedicalMedical Equipment Manufacturing

Investors

Brainsway Ltd.

Description

Neurolief, a Coral Springs, FL-based medical technology company, has raised $6M from BrainsWay Ltd. This investment follows the FDA Premarket Approval of its Proliv™Rx brain neuromodulation system. The funds will be used to expand operations and enhance R&D efforts. Led by CEO Scott Drees, Neurolief focuses on non-invasive therapies for mental health conditions.

Quick answer

Neurolief raised $6 Million in a Funding Round round, dated March 30, 2026. Investors: Brainsway Ltd. Neurolief is based in Tampa, Florida, United States.

How much did Neurolief raise?
Neurolief raised $6 Million in a Funding Round round on March 30, 2026.
Who invested in Neurolief?
Brainsway Ltd. is named as investors in this round.
What does Neurolief do?
Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression.
Where is Neurolief based and how big is it?
Neurolief is based in Tampa, Florida, United States.

Source: Fundz verified event record.

Who else raised in Medical and Medical Equipment Manufacturing around the same time

Companies in the same sectors as Neurolief that raised within 45 days of this round, from Fundz verified event records.

  • Butterfly Medical Ltd raised $21M (Series C) on May 14, 2026.
  • Sedivention raised $3.4M (Seed) on May 7, 2026.
  • Citius Oncology raised $37M on May 6, 2026.
  • Shuttle Pharmaceuticals Holdings raised $10M on April 30, 2026.
  • PlaqueTec raised $5M (Funding Round) on April 27, 2026.
  • Nervonik raised $53M (Series B) on April 27, 2026.

Who to call at Neurolief, and when

A new round usually means Neurolief is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neurolief raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurolief, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurolief. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neurolief

Location

Tampa, Florida, United States

About

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s devices either complement or provide an alternative to pharmaceutical therapies, which are often ineffective and are associated with potential short- and long-term adverse effects. Neurolief’s products are groundbreaking electronic head mounted devices designed to concurrently target major neural pathways in the head and thereby affect brain regions that are involved in control and modulation of pain and mood. These devices are intended to provide a highly effective, side-effects free treatment for the hundreds of millions of patients worldwide. Neurolief is led by a seasoned team with extensive experience and successful track record developing multiple neuromodulation devices for patients with central nervous system deficiencies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurolief raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neurolief's next move

See what Strategic adds

Neurolief raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.